The effect of liver transplantation on patient-centred outcomes: A propensity-score matched analysis

Abstract

Absolute standardised mean difference (aSMD), average treatment effect (ATE), average treatment effect on the control (ATC), average treatment effect on the treated (ATT), body mass index (BMI), donation after brain death (DBD), donation after circulatory death (DCD), hepatocellular carcinoma (HCC), health-related quality of life (HR-QoL), Model of End Stage Liver Disease (MELD), propensity-score matching (PSM), Short form of liver disease quality of life (SF-LDQOL). 10. Conflict of interest statement: None.

Contemporary trends and outcomes in aortic valve replacement in patients with end‐stage liver disease

“…This translates into a lower hospital length of stay, lower cost, as well as lower complication rate. Since patients with ESLD are at high‐risk of postoperative complications due to several pathophysiological factors including coagulopathy, increased risk of infection, fluid and electrolyte shifts, with limited respiratory and renal reserve, they are very likely to benefit from less invasive option provided by TAVR . Therefore, in conclusion, our study supports TAVR is a safe option and a viable treatment options for aortic valve stenosis in patients with ESLD.…”

Beyond Survival: Targeting Health‐Related Quality of Life Outcomes After Liver Transplantation

“…Most LT recipients experience a significant improvement in HRQOL soon after transplant compared with pretransplantation measurement (Table 1). [6][7][8][9][10][11][12][13][14][15][16][17][18] This occurs within the first month by measurement with the SF-36 in both physical and MH summary scores 6 and is supported at 3 months posttransplant, except in BP. 7 Adding the CLDQ disease-specific questionnaire to the SF-36 generic questionnaire between 2 and 23 months posttransplant (median, 4 months) demonstrates improvement in all aspects of HRQOL after transplant, and MH scores recover to population norms as well.…”

Long‐term outcomes after liver transplantation for ACLF – Don’t forget quality of life!

“…While it is clear that the main driver of our work is to improve patients’ survival, functional recovery and health‐related quality of life are also essential parts of successful transplantation. From a general point of view, LT is associated with improved functional recovery and health‐related quality of life, 8,9 although some studies have demonstrated that the social domain and cognitive function do not reach the level of the general population after surgery 10 . Quality of life after solid organ transplantation is determined by comorbidities, pre and peri‐operative clinical courses, graft function, side effects of medications, particularly immunosuppressants, and psychological and socioeconomic factors 11 .…”